IL127281A0 - Novel devices for transdermal administering of trimegestone - Google Patents

Novel devices for transdermal administering of trimegestone

Info

Publication number
IL127281A0
IL127281A0 IL12728197A IL12728197A IL127281A0 IL 127281 A0 IL127281 A0 IL 127281A0 IL 12728197 A IL12728197 A IL 12728197A IL 12728197 A IL12728197 A IL 12728197A IL 127281 A0 IL127281 A0 IL 127281A0
Authority
IL
Israel
Prior art keywords
trimegestone
novel devices
transdermal administering
transdermal
administering
Prior art date
Application number
IL12728197A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of IL127281A0 publication Critical patent/IL127281A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
IL12728197A 1996-06-11 1997-06-10 Novel devices for transdermal administering of trimegestone IL127281A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607208A FR2749586B1 (fr) 1996-06-11 1996-06-11 Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
PCT/FR1997/001023 WO1997047333A1 (fr) 1996-06-11 1997-06-10 Nouveaux dispositifs destines a l'administration transdermique de la trimegestone

Publications (1)

Publication Number Publication Date
IL127281A0 true IL127281A0 (en) 1999-09-22

Family

ID=9492919

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12728197A IL127281A0 (en) 1996-06-11 1997-06-10 Novel devices for transdermal administering of trimegestone

Country Status (23)

Country Link
EP (1) EP0906127B1 (xx)
JP (1) JP2000514416A (xx)
CN (1) CN1110327C (xx)
AR (1) AR013580A1 (xx)
AT (1) ATE216269T1 (xx)
AU (1) AU717335B2 (xx)
BR (1) BR9709690A (xx)
CA (1) CA2257902A1 (xx)
CZ (1) CZ295227B6 (xx)
DE (1) DE69712057T2 (xx)
DK (1) DK0906127T3 (xx)
ES (1) ES2173453T3 (xx)
FR (1) FR2749586B1 (xx)
HU (1) HU225034B1 (xx)
IL (1) IL127281A0 (xx)
NO (1) NO315149B1 (xx)
PL (1) PL189533B1 (xx)
PT (1) PT906127E (xx)
RU (1) RU2204417C2 (xx)
TR (1) TR199802578T2 (xx)
TW (1) TW474826B (xx)
WO (1) WO1997047333A1 (xx)
ZA (1) ZA975168B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782635B1 (fr) * 1998-08-27 2001-09-14 Oreal Dispositif aerosol contenant un polycondensat comprenant au moins un motif polyurethanne et/ou polyuree
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
ES2626784T3 (es) * 2003-10-28 2017-07-26 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos
EP1699430A1 (en) * 2003-12-05 2006-09-13 Namibia Medical Investments (PTY) Limited Patch
JP2006230930A (ja) * 2005-02-28 2006-09-07 Alcare Co Ltd 貼付材
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel

Also Published As

Publication number Publication date
PL330535A1 (en) 1999-05-24
DE69712057T2 (de) 2002-10-02
AU3266097A (en) 1998-01-07
TW474826B (en) 2002-02-01
ES2173453T3 (es) 2002-10-16
RU2204417C2 (ru) 2003-05-20
HUP9903340A2 (hu) 2000-03-28
HU225034B1 (en) 2006-05-29
HUP9903340A3 (en) 2000-04-28
JP2000514416A (ja) 2000-10-31
EP0906127B1 (fr) 2002-04-17
AU717335B2 (en) 2000-03-23
DE69712057D1 (de) 2002-05-23
FR2749586A1 (fr) 1997-12-12
DK0906127T3 (da) 2002-08-05
BR9709690A (pt) 1999-08-10
CN1110327C (zh) 2003-06-04
AR013580A1 (es) 2001-01-10
CA2257902A1 (fr) 1997-12-18
CZ295227B6 (cs) 2005-06-15
ATE216269T1 (de) 2002-05-15
NO985791D0 (no) 1998-12-10
EP0906127A1 (fr) 1999-04-07
ZA975168B (en) 1998-07-22
FR2749586B1 (fr) 1998-08-07
CN1227503A (zh) 1999-09-01
NO985791L (no) 1999-02-11
NO315149B1 (no) 2003-07-21
CZ410798A3 (cs) 1999-09-15
WO1997047333A1 (fr) 1997-12-18
PT906127E (pt) 2002-09-30
PL189533B1 (pl) 2005-08-31
TR199802578T2 (xx) 1999-03-22

Similar Documents

Publication Publication Date Title
EP0800364A4 (en) PERCUTANEOUS ADMINISTRATION OF APOMORPHIN
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
IL130027A (en) Rosiglitazone - glyburide synergistic combinations for treatment of diabetes
AU5588894A (en) An improved splint/therapeutic device
HK1022835A1 (en) Pharmaceutical composition for treatment of diabetes
GB9601724D0 (en) Therapeutic agents
HUP0001748A3 (en) Transdermal device for the delivery of testosterone
EP0941039A4 (en) TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT")
EP0846473A4 (en) IONTOPHORESE PLASTER
IL116895A0 (en) Transdermal formulation
GB9600235D0 (en) Therapeutic agents
GB9603755D0 (en) Therapeutic agents
HUP9802070A3 (en) Transdermal formulation
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
HUP9801130A3 (en) Transdermal therapeutic system for administering testosterone
GB9600143D0 (en) Therapeutic compounds
IL127281A0 (en) Novel devices for transdermal administering of trimegestone
IL116999A0 (en) Transdermal formulation
GB9605065D0 (en) Therapeutic agents
GB9609374D0 (en) Therapeutic agents
AU6821196A (en) Transdermal administration of vorozole
AU3723695A (en) Transdermal device for delivery of levonorgestrel
ZA938116B (en) Transdermal delivery of ketorolac
EP0668759A4 (en) TRANSDERMAL INTAKE OF KETOROLAC.
GB9626450D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees